An international research team has secured nearly $800,000 to advance a potential regenerative therapy for MS toward clinical ...
The US Food and Drug Administration (FDA) has granted de novo marketing authorisation to TISSIUM’s COAPTIUM CONNECT, representing the first atraumatic option for repairing peripheral nerve damage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback